Medicare Enrolled
Dr. Reema Batra, MD
Hematology & Oncology · La Mesa, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Batra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Batra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Batra
Dr. Reema Batra is a hematology & oncology specialist in La Mesa, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Batra performed 172,204 Medicare services across 1,309 unique beneficiaries.
Between the years covered by Open Payments, Dr. Batra received a total of $59,160 from 86 pharmaceutical and/or device companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Batra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 3% volume in CA
$59,160 industry payments
Medicare Practice Summary
Medicare Utilization ↗172,204
Medicare services
Top 3% in CA for hematology & oncology
1,309
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,567 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
106,500 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
36,800 | $2 | $10 |
| Pembrolizumab injection (Keytruda) | 16,800 | $43 | $90 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,725 | $0 | $3 |
| Injection, fulvestrant, 25 mg | 2,460 | $8 | $146 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,010 | $1 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
648 | $11 | $45 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
644 | $14 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
560 | $100 | $200 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
453 | $118 | $295 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
432 | $68 | $134 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
356 | $1 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
297 | $57 | $140 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
280 | $30 | $73 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
226 | $6 | $27 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
224 | $18 | $45 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
144 | $25 | $64 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
136 | $1 | $2 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
132 | $59 | $140 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
79 | $24 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $133 | $355 |
| Blood draw from central venous catheter A procedure to collect a blood sample directly from a central venous tube or catheter. |
64 | $25 | $60 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
39 | $94 | $238 |
| New patient office visit, complex (60-74 min) | 37 | $181 | $385 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $143 | $360 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $130 | $270 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
23 | $1 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $61 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
62.6% high complexity
36.7% medium
0.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$59,160
Total received (2018-2024)
Avg $8,451/year across 7 years
Top 11% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,517 (80.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,597 (16.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,046 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,184
2023
$10,624
2022
$9,584
2021
$10,413
2020
$3,374
2019
$10,504
2018
$477
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$8,634
AstraZeneca Pharmaceuticals LP
$2,046
Merck Sharp & Dohme LLC
$297
PFIZER INC.
$258
Novartis Pharmaceuticals Corporation
$252
ABBVIE INC.
$158
Celgene Corporation
$137
Daiichi Sankyo Inc.
$136
Aurinia Pharma U.S., Inc.
$106
Eisai Inc.
$105
Alexion Pharmaceuticals, Inc.
$104
Astellas Pharma US Inc
$102
Incyte Corporation
$102
Takeda Pharmaceuticals U.S.A., Inc.
$92
Janssen Biotech, Inc.
$92
E.R. Squibb & Sons, L.L.C.
$92
Bayer Healthcare Pharmaceuticals Inc.
$89
BeiGene USA, Inc.
$80
ARRAY BIOPHARMA INC
$68
Ipsen Biopharmaceuticals, Inc
$61
TerSera Therapeutics LLC
$56
SpringWorks Therapeutics, Inc.
$54
SOBI, INC
$53
Gilead Sciences, Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$51
Exelixis Inc.
$50
Genentech USA, Inc.
$49
Mirati Therapeutics, Inc.
$47
Karyopharm Therapeutics Inc.
$45
Sumitomo Pharma America, Inc.
$35
PharmaEssentia USA Corporation
$34
Dendreon Pharmaceuticals LLC
$34
Lilly USA, LLC
$32
ADC Therapeutics America, Inc.
$32
Deciphera Pharmaceuticals Inc.
$32
Rigel Pharmaceuticals, Inc.
$31
Genmab U.S., Inc.
$29
Regeneron Healthcare Solutions, Inc.
$27
Coherus Biosciences Inc.
$26
Tempus AI, Inc
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Blueprint Medicines Corporation
$25
RECORDATI_RARE_DISEASES_INC.
$25
PROGENICS PHARMACEUTICALS, INC.
$25
GlaxoSmithKline, LLC.
$24
Pharmacosmos Therapeutics Inc.
$24
Novo Nordisk Inc
$23
Stemline Therapeutics Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
Fennec Pharmaceuticals, Inc.
$20
Adaptive Biotechnologies Corporation
$20
Agios Pharmaceuticals, Inc.
$19
Acrotech Biopharma Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Immunocore Limited
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Aveo Pharmaceuticals, Inc.
$18
Alnylam Pharmaceuticals Inc.
$14
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$47,524
AstraZeneca Pharmaceuticals LP
$2,384
Novartis Pharmaceuticals Corporation
$694
PFIZER INC.
$579
Merck Sharp & Dohme LLC
$451
Daiichi Sankyo Inc.
$340
Celgene Corporation
$330
Janssen Biotech, Inc.
$324
Pharmacyclics LLC, An AbbVie Company
$322
Amgen Inc.
$257
Eisai Inc.
$243
E.R. Squibb & Sons, L.L.C.
$226
Astellas Pharma US Inc
$212
Incyte Corporation
$212
Takeda Pharmaceuticals U.S.A., Inc.
$201
Pharmacyclics LLC, an AbbVie Company
$199
Gilead Sciences, Inc.
$171
Seagen Inc.
$169
ABBVIE INC.
$158
Alexion Pharmaceuticals, Inc.
$151
Genentech USA, Inc.
$148
ARRAY BIOPHARMA INC
$145
Karyopharm Therapeutics Inc.
$145
Stemline Therapeutics Inc.
$142
BeiGene USA, Inc.
$142
PharmaEssentia USA Corporation
$131
Bayer Healthcare Pharmaceuticals Inc.
$128
Regeneron Healthcare Solutions, Inc.
$127
Ipsen Biopharmaceuticals, Inc
$126
GlaxoSmithKline, LLC.
$123
Lilly USA, LLC
$111
Merck Sharp & Dohme Corporation
$109
Aurinia Pharma U.S., Inc.
$106
Bayer HealthCare Pharmaceuticals Inc.
$101
SOBI, INC
$97
Deciphera Pharmaceuticals Inc.
$94
AbbVie Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
Rigel Pharmaceuticals, Inc.
$86
Exelixis Inc.
$84
SANOFI-AVENTIS U.S. LLC
$83
ADC Therapeutics America, Inc.
$81
TerSera Therapeutics LLC
$79
PUMA BIOTECHNOLOGY, INC.
$70
Coherus Biosciences Inc.
$70
Adaptive Biotechnologies Corporation
$69
Mirati Therapeutics, Inc.
$68
Sumitomo Pharma America, Inc.
$67
Acrotech Biopharma Inc.
$62
SpringWorks Therapeutics, Inc.
$54
Genmab U.S., Inc.
$53
Kyowa Kirin, Inc.
$52
Blueprint Medicines Corporation
$49
AVEO Pharmaceuticals, Inc.
$43
Novo Nordisk Inc
$42
SERVIER PHARMACEUTICALS LLC
$41
Clovis Oncology, Inc.
$41
MorphoSys, US Inc.
$40
Janssen Pharmaceuticals, Inc
$37
Puma Biotechnology, Inc.
$34
Dendreon Pharmaceuticals LLC
$34
EISAI INC.
$33
Alnylam Pharmaceuticals Inc.
$29
Taiho Oncology, Inc.
$29
Verastem, Inc.
$26
Tempus AI, Inc
$26
RECORDATI_RARE_DISEASES_INC.
$25
PROGENICS PHARMACEUTICALS, INC.
$25
ImmunoGen, Inc.
$24
TAIHO ONCOLOGY, INC.
$24
Pharmacosmos Therapeutics Inc.
$24
Myovant Sciences Inc.
$22
Novocure Inc.
$22
Teva Pharmaceuticals USA, Inc.
$21
Fennec Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$19
Apellis Pharmaceuticals, Inc.
$19
MENARINI SILICON BIOSYSTEMS, INC.
$18
Immunocore Limited
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Aveo Pharmaceuticals, Inc.
$18
EMD Serono, Inc.
$16
Heron Therapeutics, Inc.
$14
Foundation Medicine, Inc.
$13
Seattle Genetics, Inc.
$13
Emmaus Medical, Inc.
$9
Top 3 companies account for 85.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · ALUNBRIG · AMVUTTRA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARESTON · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JARDIANCE · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPKYNIS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Neulasta · Novoeight · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vitrakvi · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Batra is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 11% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Batra experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Batra performed 106,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Batra receive payments from pharmaceutical companies?
Yes. Dr. Batra received a total of $59,160 from 86 companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Batra's costs compare to other hematology & oncology specialists in La Mesa?
Dr. Batra's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Batra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in La Mesa
Browse hematology & oncology specialists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology